I. Bozicevic, S. Handanagic, S.Z. Lepej, J. Begovac

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Varicella vaccination: a laboured take-off

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Migrant health—a cause for concern?

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Virological tools to diagnose and monitor hepatitis C virus infection

Refugee crisis and re-emergence of forgotten infections in Europe

R. Cantón Clinical Microbiology and Infection

I. Bozicevic, S. Handanagic, S.Z. Lepej, J. Begovac

Nocardiosis in Quebec, Canada, 1988–2008

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

Vector control: a cornerstone in the malaria elimination campaign

The role of vaccination in preventing pneumococcal disease in adults

Towards the risk of yellow fever transmission in Europe

J. Logar, B. Šoba, T. Premru-Sršen, Ž. Novak-Antolič

P.L. Lopalco, P. Carrillo Santisteve

Training for the infectious diseases speciality in Norway

B. Gordts Clinical Microbiology and Infection

CMI editorial report 2011 Clinical Microbiology and Infection

The clinical efficacy of triclosan/copolymer and other common therapeutic approaches to periodontal health R.M. Davies Clinical Microbiology and Infection

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008 C.-K. Tan, C.-C.

V Duque, ÁA. Holguín, M. Silvestre, J. GonzÁAlez-Lahoz, V. Soriano

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Sexually acquired Zika virus: a systematic review

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

An after-hours clinical liaison blood culture service—is it worth it?

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Influenza A(H1N1)2009 in the French Pacific territories: assessment of the epidemic wave during the austral winter Epidemiological Task Group for Overseas.

C. Wongsrichanalai, C.H. Sibley Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger

The state of measles and rubella in the WHO European Region, 2013

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

The emerging and re-emerging human immunodeficiency virus epidemics in Europe I. Bozicevic, S. Handanagic, S.Z. Lepej, J. Begovac Clinical Microbiology and Infection Volume 19, Issue 10, Pages 917-929 (October 2013) DOI: 10.1111/1469-0691.12313 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Annual rates of reported HIV infections per 100 000 inhabitants in 19 countries of the WHO region of Western Europe (West) for the period 2002 to 2011. The black line represents a linear trend line for the region. Data source: ECDC/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2011. Stockholm: ECDC; 2012. Clinical Microbiology and Infection 2013 19, 917-929DOI: (10.1111/1469-0691.12313) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Annual rates of reported HIV infections per 100 000 inhabitants in 15 countries of the WHO region of central Europe (Centre) for the period 2002 to 2011. The black line represents a linear trend line for the region. BH, Bosnia and Herzegovina. Data source: ECDC/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2011. Stockholm: ECDC; 2012. Clinical Microbiology and Infection 2013 19, 917-929DOI: (10.1111/1469-0691.12313) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Annual rates of reported HIV infections per 100 000 inhabitants in 14 countries of the WHO region of Eastern Europe and central Asia (East) for the period 2002 to 2011. The black line represents a linear trend line for the region. Data source: ECDC/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2011. Stockholm: ECDC; 2012. Clinical Microbiology and Infection 2013 19, 917-929DOI: (10.1111/1469-0691.12313) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions